Metagenomi Cash on Hand 2022-2025 | MGX

Metagenomi cash on hand from 2022 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Metagenomi Annual Cash on Hand
(Millions of US $)
2024 $248
2023 $271
2022 $362
2021 $108
Metagenomi Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $226
2024-12-31 $248
2024-09-30 $275
2024-06-30 $300
2024-03-31 $327
2023-12-31 $271
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $362
2021-12-31 $108
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.062B $0.052B
Metagenomi Inc. is a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox. Metagenomi Inc. is based in EMERYVILLE, Calif.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.311B 32.75
Zoetis (ZTS) United States $74.020B 27.62
Daiichi Sankyo, - (DSNKY) Japan $51.315B 26.11
Takeda Pharmaceutical (TAK) Japan $46.678B 9.28
Sandoz Group AG (SDZNY) Switzerland $21.655B 0.00
Summit Therapeutics (SMMT) United States $19.042B 0.00
Merck (MKKGY) Germany $17.125B 12.55
United Therapeutics (UTHR) United States $14.201B 12.56
Shionogi (SGIOY) Japan $14.121B 14.15
Neurocrine Biosciences (NBIX) United States $12.137B 41.57
IPSEN (IPSEY) France $9.821B 0.00
Orion OYJ (ORINY) Finland $9.323B 25.21
Corcept Therapeutics (CORT) United States $8.145B 66.22
Stevanato Group S.p.A (STVN) Italy $6.917B 42.30
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.030B 0.00
Grifols, S.A (GRFS) Spain $5.659B 0.00
Ionis Pharmaceuticals (IONS) United States $5.303B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.843B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.030B 10.61
Hypermarcas (HYPMY) Brazil $2.873B 18.90
Crinetics Pharmaceuticals (CRNX) United States $2.762B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.285B 12.36
BioCryst Pharmaceuticals (BCRX) United States $2.258B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.910B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.785B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.705B 0.00
Indivior (INDV) United States $1.630B 6.92
Evotec AG (EVO) Germany $1.518B 0.00
ARS Pharmaceuticals (SPRY) United States $1.436B 0.00
Guardian Pharmacy Services (GRDN) United States $1.401B 0.00
Dyne Therapeutics (DYN) United States $1.330B 0.00
Ocular Therapeutix (OCUL) United States $1.106B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Harrow (HROW) United States $0.966B 0.00
Ardelyx (ARDX) United States $0.950B 0.00
Collegium Pharmaceutical (COLL) United States $0.947B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.876B 0.00
Enliven Therapeutics (ELVN) United States $0.785B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Akebia Therapeutics (AKBA) United States $0.767B 0.00
Xeris Biopharma Holdings (XERS) United States $0.755B 0.00
AleAnna (ANNA) United States $0.675B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.566B 12.30
KalVista Pharmaceuticals (KALV) United States $0.558B 0.00
Xencor (XNCR) United States $0.552B 0.00
Regulus Therapeutics (RGLS) United States $0.548B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.464B 0.00
Zevra Therapeutics (ZVRA) United States $0.462B 0.00
Altimmune (ALT) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.434B 9.07
Oruka Therapeutics (ORKA) United States $0.428B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.421B 0.00
CytoDyn (CYDY) United States $0.406B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Verve Therapeutics (VERV) United States $0.382B 0.00
Organogenesis (ORGO) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.351B 9.48
Savara (SVRA) United States $0.335B 0.00
Heron Therapeutics (HRTX) United States $0.288B 0.00
Nature's Sunshine Products (NATR) United States $0.272B 25.14
Tonix Pharmaceuticals Holding (TNXP) United States $0.271B 0.00
Aquestive Therapeutics (AQST) United States $0.253B 0.00
MediWound (MDWD) Israel $0.230B 0.00
ProKidney (PROK) United States $0.214B 0.00
Journey Medical (DERM) United States $0.181B 0.00
Wellgistics Health (WGRX) United States $0.180B 0.00
Nanobiotix S.A (NBTX) France $0.180B 0.00
Esperion Therapeutics (ESPR) United States $0.163B 0.00
OmniAb (OABI) United States $0.162B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Profound Medical (PROF) Canada $0.159B 0.00
4D Molecular Therapeutics (FDMT) United States $0.158B 0.00
Aclaris Therapeutics (ACRS) United States $0.138B 0.00
Liminatus Pharma (LIMN) $0.132B 0.00
Aldeyra Therapeutics (ALDX) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.132B 0.00
Nektar Therapeutics (NKTR) United States $0.126B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Korro Bio (KRRO) United States $0.120B 0.00
Larimar Therapeutics (LRMR) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
VAXART, INC (VXRT) United States $0.105B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Cardiol Therapeutics (CRDL) Canada $0.096B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.090B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Inotiv (NOTV) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.61
Cumberland Pharmaceuticals (CPIX) United States $0.080B 59.33
Pyxis Oncology (PYXS) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.071B 0.00
Unicycive Therapeutics (UNCY) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Nutriband (NTRB) United States $0.067B 0.00
Surrozen (SRZN) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Rafael Holdings (RFL) United States $0.032B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
PolyPid (PYPD) Israel $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.82
Talphera (TLPH) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Incannex Healthcare (IXHL) Australia $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00